Delta-Fly Pharma is a legitimate, publicly traded Japanese pharmaceutical company (TSE: 4598) specializing in module drug development for cancer (e.g., DFP-10917). However, the submission quality is critically low, containing false claims ('most people have used my product', 'everyone' audience) and missing financial data despite the company's public status (Market Cap ~$37M). While the project's real-world utility and underlying technology are high, the score is heavily penalized by the inaccuracy and laziness of the submission.
Ready to Compete for $150k+ in Prizes?
Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes
Score Breakdown
Project Details
Algorithm Insights
Recommendations to Increase Usefulness Score
Document User Growth
Provide specific metrics on user acquisition and retention rates
Showcase Revenue Model
Detail sustainable monetization strategy and current revenue streams
Expand Evidence Base
Include testimonials, case studies, and third-party validation
Technical Roadmap
Share development milestones and feature completion timeline